CytomX Therapeutics Inc (CTMX) — Cash Flow Quality Index
CytomX Therapeutics Inc (CTMX) has a Cash Flow Quality Index of -0.89x as of March 2025. Operating cash flow of $-21.04 Million is below net income of $23.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CTMX cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CytomX Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for CytomX Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CytomX Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CytomX Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for CytomX Therapeutics Inc. For live market cap and the full company financial profile, see CTMX market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -2.71x | $-86.23 Million | $31.87 Million | — |